Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Ubl5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of UBL5 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of UBL5 mRNA] | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Ubl5 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of UBL5 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL5 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of UBL5 mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of UBL5 mRNA | CTD | PMID:23019147 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | affects splicing | ISO | UBL5 (Homo sapiens) | 6480464 | Metribolone affects the splicing of UBL5 mRNA | CTD | PMID:17010196 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL5 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UBL5 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UBL5 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ubl5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of UBL5 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UBL5 mRNA | CTD | PMID:15328365 | 2-hydroxypropanoic acid | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of UBL5 mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | UBL5 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of UBL5 mRNA | CTD | PMID:21179406 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Ubl5 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of UBL5 mRNA | CTD | PMID:18648102 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of UBL5 mRNA | CTD | PMID:30047161 | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of UBL5 protein | CTD | PMID:33236894 | all-trans-retinoic acid | increases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of UBL5 mRNA | CTD | PMID:17218384 and PMID:33167477 | arsenite(3-) | multiple interactions | ISO | UBL5 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to UBL5 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to UBL5 promoter] | CTD | PMID:19654925 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of UBL5 mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | ISO | Ubl5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of UBL5 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | ISO | UBL5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of UBL5 mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of UBL5 mRNA | CTD | PMID:25181051 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of UBL5 promoter | CTD | PMID:22457795 | clobetasol | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | Clobetasol results in increased expression of UBL5 mRNA | CTD | PMID:27462272 | clofibrate | decreases expression | ISO | Ubl5 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of UBL5 mRNA | CTD | PMID:17585979 | clofibrate | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of UBL5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBL5 mRNA] | CTD | PMID:17585979 | cobalt dichloride | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of UBL5 mRNA | CTD | PMID:19376846 | dicrotophos | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of UBL5 mRNA | CTD | PMID:28302478 | diuron | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Diuron results in decreased expression of UBL5 mRNA | CTD | PMID:35967413 | doxorubicin | increases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of UBL5 mRNA | CTD | PMID:29803840 | epoxiconazole | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of UBL5 mRNA | CTD | PMID:35436446 | ethanol | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of UBL5 mRNA | CTD | PMID:30319688 | fenthion | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | Fenthion results in increased expression of UBL5 mRNA | CTD | PMID:34813904 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of UBL5 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of UBL5 mRNA] | CTD | PMID:22206623 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of UBL5 mRNA | CTD | PMID:24136188 | ivermectin | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of UBL5 protein | CTD | PMID:32959892 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of UBL5 mRNA | CTD | PMID:30047161 | paracetamol | multiple interactions | ISO | Ubl5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of UBL5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBL5 mRNA] | CTD | PMID:17585979 | phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of UBL5 mRNA | CTD | PMID:20345932 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of UBL5 mRNA | CTD | PMID:30047161 | rac-lactic acid | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of UBL5 mRNA | CTD | PMID:30851411 | sodium arsenite | increases expression | ISO | UBL5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of UBL5 mRNA | CTD | PMID:28595984 and PMID:34032870 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of UBL5 mRNA | CTD | PMID:30047161 | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of UBL5 mRNA | CTD | PMID:24136188 | tamoxifen | affects expression | ISO | Ubl5 (Mus musculus) | 6480464 | Tamoxifen affects the expression of UBL5 mRNA | CTD | PMID:17555576 | tert-butyl hydroperoxide | decreases expression | ISO | UBL5 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of UBL5 mRNA | CTD | PMID:15336504 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of UBL5 mRNA | CTD | PMID:26496021 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of UBL5 mRNA | CTD | PMID:33387578 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of UBL5 mRNA | CTD | PMID:34492290 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of UBL5 mRNA | CTD | PMID:22967744 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of UBL5 mRNA | CTD | PMID:33387578 | triptonide | increases expression | ISO | Ubl5 (Mus musculus) | 6480464 | triptonide results in increased expression of UBL5 mRNA | CTD | PMID:33045310 | |